JENNIFER CARVER

CIK 1663163 · Chief Operating Officer · last filed 2026-02-05

JENNIFER CARVER is a Chief Operating Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider had shares withheld for taxes covering $3.1K of REVBW on Feb 5, 2026. Across all open-market trades the lifetime net is +$151.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $117 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$117

Companies

2

Total Filings

24

Lifetime Open-Market Net

$151.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
REVBW Director 12,758 $0.01 $117 $0 5 2026-02-05
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Chief Operating Officer 14,049 $6.22 $87.4K $151.9K 19 2019-03-04

Recent Filings

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-05 REVBW Tax (F) −1,661 -$3.1K EDGAR
2026-01-12 REVBW Grant (A) +41,981 $37.8K EDGAR
2025-10-31 REVBW Grant (A) +15,625 $20.0K EDGAR
2025-02-13 REVBW Grant (A) +181 $700 EDGAR
2023-04-18 REVBW Grant (A) $0 EDGAR
2019-03-04 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +230 $1.1K EDGAR
2019-02-19 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +230 $1.2K EDGAR
2019-02-04 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +1,260 $6.5K EDGAR
2019-01-25 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) $0 EDGAR
2019-01-17 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +213 $1.2K EDGAR
Showing 110 of 24
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.